News
Public · Published
Wells Fargo maintains Hinge Health at Overweight, raises price target to $132 from $103
Wells Fargo kept an Overweight rating on Hinge Health and raised its price target to $132 from $103, a 28.2% increase. That target implies 14.3% upside from the November 2 close of $115.48.
Published:
Updated:
What happened
Wells Fargo kept an Overweight rating on Hinge Health and raised its price target to $132 from $103, a 28.2% increase. That target implies 14.3% upside from the November 2 close of $115.48.
Confirmed
Global impact / market context
A higher target signals Wells Fargo expects more share price gain. Because a target is only a forecast, it does not guarantee returns. It may draw investor attention to Hinge Health and support demand for the stock.
Analyst inference
Other recent analyst notes set targets from $134 to $150, all above Wells Fargo's new figure. That clustering suggests broadly positive expectations across research firms, though targets vary and remain opinions rather than commitments.
Analyst inference
What to watch
- Watch whether Hinge Health shares move toward the $132 target from the $115.48 close, a gap of 14.3% that the note describes as implied upside. Confirmed
- Watch whether other analysts change their ratings or targets, since current targets ranging from $134 to $150 sit above Wells Fargo's new $132 level. Proposed
- Watch the company's next results for revenue and cost trends, because analyst targets depend on profit expectations that can shift after new financial disclosures. Analyst inference
Evidence
- Original source link unavailable